Steven A. Rosenberg, MD, PhD, chief, Surgery Branch, senior investigator, head, Tumor Immunology Section, National Cancer Institute, explains advancements in adoptive cell therapy for the treatment of melanoma.
Steven A. Rosenberg, MD, PhD
Advertisement
Articles by Steven A. Rosenberg, MD, PhD
Advertisement
Latest Updated Articles
Dr. Steven Rosenberg on the Curative Potential of Adoptive Cell TherapyPublished: January 8th 2016 | Updated:
Advertisement
Advertisement
Trending on CGTlive®
1
Tr1X's Multiple Sclerosis Cell Therapy TRX319 Cleared for US Trial
2
Patients Treated With Spur Therapeutics’ Gaucher Disease Gene Therapy FLT201 Maintain Clinical Benefit for Up to 2 Years
3
Around the Helix: Cell and Gene Therapy Company Updates – October 15, 2025
4
